Open AccessInflammatory myofibroblastic tumor: A demographic, clinical and therapeutic study of 92 cases
Author(s) -
Guo Xiang Fu,
Chu Chu Xu,
Nian Fang Yao,
Jiabin Gu,
Han Jiang,
Xu Han
Publication year - 2019
Publication title -
mathematical biosciences and engineering
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.451
H-Index - 45
eISSN - 1551-0018
pISSN - 1547-1063
DOI - 10.3934/mbe.2019339
Subject(s) - medicine , radiation therapy , epidemiology , demographics , histopathology , adjuvant radiotherapy , head and neck , disease , soft tissue , oncology , pathology , surgery , demography , sociology
Inflammatory myofibroblastic tumors (IMT) was a rare kind of tumor defined by WHO since 2012. Little was known about this disease. There were controversies about IMT's behavior, predilection site, age distribution, and the best treatment methods. Here we provided a systematic overview on tumor demographical, clinical, biological features as well as treatment efficacy based on real cases from Surveillance, Epidemiology, and End Results (SEER) database.